Lurasidone DP-2 Impurity - Request Quote
Lurasidone DP-2 Impurity
| SZ CAT No: | SZ-L035086 |
| CAS No | NA |
| Mol.F. | C28H38N4O3S |
| Mol.Wt. | 510.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lurasidone DP-2 Impurity is chemically (1R,2S,3R,4S)-3-((((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)carbamoyl)bicyclo[2.2.1]heptane-2-carboxylic acid. Lurasidone DP-2 Impurity is supplied with detailed characterization data compliant with regulatory guideline. Lurasidone DP-2 Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lurasidone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Lurasidone DP-2 Impurity
Purchase Lurasidone DP-2 Impurity
Lurasidone DP-2 Impurity suppliers
Lurasidone DP-2 Impurity manufacturers
Lurasidone DP-2 Impurity price
Order Lurasidone DP-2 Impurity
Enquire Lurasidone DP-2 Impurity
Lurasidone DP-2 Impurity cost
Lurasidone DP-2 Impurity Supplier
Lurasidone DP-2 Impurity Distributor
Lurasidone DP-2 Impurity for Method Validation
Lurasidone Reference Standard
Lurasidone DP-2 Impurity for ANDA Filing
Lurasidone DP-2 Impurity for Forced Degradation Studies
Lurasidone DP-2 Impurity Identification Standards
Lurasidone DP-2 Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


